← All indications
Premature Birth
CHILDBIRTH before 37 weeks of PREGNANCY (259 days from the first day of the mother's last menstrual period, or 245 days after FERTILIZATION).
Drugs by status
Approved for this indication (1)
Phase 4 trials (44)
- metronidazole
- vitamin d3
- acetylcysteine
- urea
- beta carotene
- epoetin
- canola oil
- cefazolin
- ceftazidime
- progesterone
- betamethasone
- nifedipine
- hydrocortisone
- icosapent ethyl
- magnesium oxide
- amoxicillin
- krill oil
- levocarnitine
- nitric oxide
- Atosiban
- poractant alfa
- indomethacin
- caffeine
- surfactant
- ceftriaxone
- acetylsalicylic acid
- sulbactam
- bevacizumab
- glucose
- multi-valent pneumococcal conjugate vaccine
- +14 more
Phase 3 trials (29)
- metformin
- melatonin
- phenylephrine
- iron
- arabin pessary
- prednisone
- dydrogesterone
- folic acid
- palivizumab
- pneumococcal 13-valent conjugate vaccine
- magnesium sulfate
- tropicamide
- nicotinamide
- Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine
- dexmedetomidine
- fentanyl
- sulfadoxine
- gentamicin
- midazolam
- oxygen
- multivitamins
- pyrimethamine
- prednisolone
- sodium chloride
- fish oil
- docosahexaenoic acid
- magnesium citrate
- lactobacillus reuteri
- lactobacillus rhamnosus
Phase 2 trials (9)
Phase 1 trials (6)
Organizations
Organization Involved with Phase 4 Indications (107)
- University of South Alabama
- Chongqing Women and Children's Health Center
- University of California, San Francisco
- GlaxoSmithKline
- Wake Forest University
- Bagcilar Research and Training Hospital
- Merck
- Maternite Regionale Universitaire
- Wuhan University
- Laval University
- Pontificia Universidad Javeriana
- Pennington Biomedical Research Center
- University of Kansas
- Jiao Tong University
- Beijing Bozhiyin T&S Co., Ltd.
- University of Paris
- University of Lille
- Second Military Medical University
- Pfizer
- Zhengzhou University
- Southern Medical University
- University of North Carolina at Chapel Hill
- University of Tehran
- University of Sao Paulo
- University of Texas at Houston
- University of Indonesia
- Addis Continental Institute of Public Health
- Nilratan Sircar Medical College
- Cornell University
- Jawaharlal Nehru Medical College
- +77 more
Organization Involved with Phase 3 Indications (161)
- McMaster University
- Juniper Pharmaceuticals, Inc.
- Swedish Orphan Biovitrum
- Paris Descartes University
- Nutrinia
- Northwestern University
- DSM
- Spanish Clinical Research Network
- Queen Silvia Children's Hospital, Gothenburg, Sweden
- Erzincan University
- Bayer
- University of California, San Diego
- National University of Malaysia
- Tanta University
- Cantonal Hospital Winterthur
- Tel Aviv University
- Hospital Carlos G. Durand Buenos Aires
- University of Strasbourg
- University of New Mexico
- Case Western Reserve University
- ONY
- Hospital Donación Francisco Santojanni
- Brown University
- Kantonsspital Graubünden
- Children & Women's Health Centre of BC, Vancouver, Canada
- Asociacion Mexicana para la Salud Sexual, A.C.
- University of Zurich
- National Health and Medical Research Council, Australia
- Ioltech
- CEMIC Buenos Aires
- +131 more
Organization Involved with Phase 2 Indications (104)
- Linkoping University
- Ajou University
- Tzu Chi University
- Vision Research Foundation
- B. Braun
- Nazareth Hospital
- State University of New York, Buffalo
- Children's National Medical Center
- Al Azhar University
- University of Sherbrooke
- Pediatric Eye Disease Investigator Group
- SP ZOZ Szpital Uniwersytecki w Krakowie Oddizat Neonatologii
- Novotech
- Chonnam National University
- Xiamen University
- Sanford Health
- University of Wisconsin
- New England Research Institutes
- University of Oslo
- University of Ulsan
- Hebrew University
- Jinan University
- Seoul National University
- Medipost Co Ltd.
- PHT Corporation
- Kyushu University
- Rush University
- Government of Denmark
- Wenzhou Medical University
- University of Guanjuato
- +74 more
Organization Involved with Phase 1 Indications (26)
- Universidad Complutense de Madrid
- New York University
- Maastricht University
- Ascendance Biomedical
- Syngene International
- University of Oklahoma
- University of Bari
- University of Minnesota
- University of Nebraska
- Shanghai First Maternity and Infant Hospital
- ZonMw: The Netherlands Organisation for Health Research and Development
- Creighton University
- The EMMES Corporation
- Free University of Amsterdam
- Mansoura University
- National Center for Complementary and Integrative Health (NCCIH)
- Fonds NutsOhra
- Respivant Sciences Inc.
- Arizona State University
- Icahn School of Medicine at Mount Sinai
- Smith-Kettlewell Eye Research Institute
- Alhayah National Hospital
- Menoufia University
- Virginia Center for Reproductive Medicine
- Pomeranian Medical University
- Al Hayat National Hospital
Organization Involved with Other Experimental Indications (84)
- Maatschap Cardiologie Zwolle
- St. Justine's Hospital
- Statens Serum Institut
- Danish Council for Independent Research
- Lallemand SAS
- DMK Group
- Centre for Fetal Programming, Denmark
- Evolve Biosystems, Inc.
- The Northwest Women's and Children's Hospital
- Isala Clinics, Zwolle, The Netherlands
- University of Ljubljana
- University of Iceland
- Regional Obstetrical Consultants
- Inhibitex
- Orlando Health
- Sykehuset Innlandet HF
- University of Turku
- Emek Medical Center
- Xidian University
- Baylor University
- The Baruch Padeh Medical Center, Poriya
- Nestle
- The Danish Council for Strategic Research
- Hamilton Health Sciences Corporation
- Pennsylvania State University
- Georgetown University
- Nordland Hospital
- University of Ottawa
- Sooft Italia
- Slovenian Research Agency
- +54 more